These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32793666)

  • 21. Psychosocial effects of hidradenitis suppurativa in the literature: A systematic review.
    Richards E; Joshi A
    Int J Psychiatry Med; 2024 Apr; ():912174241249215. PubMed ID: 38644350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis.
    Phan K; Charlton O; Smith SD
    Clin Exp Dermatol; 2019 Jun; 44(4):e126-e132. PubMed ID: 30730068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected].
    Patel ZS; Hoffman LK; Buse DC; Grinberg AS; Afifi L; Cohen SR; Lowes MA; Seng EK
    Curr Pain Headache Rep; 2017 Nov; 21(12):49. PubMed ID: 29094219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of metabolic syndrome and hidradenitis suppurativa.
    Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
    JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Hidradenitis Suppurativa and Metabolic Syndrome: A Systematic Review and Meta-analysis.
    Rodríguez-Zuñiga MJM; García-Perdomo HA; Ortega-Loayza AG
    Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):279-288. PubMed ID: 30846164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for the management of comorbidity in hidradenitis suppurativa.
    Dauden E; Lazaro P; Aguilar MD; Blasco AJ; Suarez C; Marin I; Queiro R; Bassas-Vila J; Martorell A; García-Campayo J
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):129-144. PubMed ID: 28796920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
    Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidities of hidradenitis suppurativa.
    Porter ML; Kimball AB
    Semin Cutan Med Surg; 2017 Jun; 36(2):55-57. PubMed ID: 28538744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa.
    Miller IM; McAndrew RJ; Hamzavi I
    Dermatol Clin; 2016 Jan; 34(1):7-16. PubMed ID: 26617352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hidradenitis suppurativa and Down syndrome: A systematic review and meta-analysis.
    Lam M; Lai C; Almuhanna N; Alhusayen R
    Pediatr Dermatol; 2020 Nov; 37(6):1044-1050. PubMed ID: 32892406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents.
    Tiri H; Jokelainen J; Timonen M; Tasanen K; Huilaja L
    J Am Acad Dermatol; 2018 Sep; 79(3):514-519. PubMed ID: 29518461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hidradenitis suppurativa and schizophrenia: a nationwide cohort study.
    Tzur Bitan D; Berzin D; Cohen AD
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):574-579. PubMed ID: 31587377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Hidradenitis Suppurativa With Body Image.
    Schneider-Burrus S; Jost A; Peters EMJ; Witte-Haendel E; Sterry W; Sabat R
    JAMA Dermatol; 2018 Apr; 154(4):447-451. PubMed ID: 29466546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Suicide Risk in Patients with Hidradenitis Suppurativa.
    Thorlacius L; Cohen AD; Gislason GH; Jemec GBE; Egeberg A
    J Invest Dermatol; 2018 Jan; 138(1):52-57. PubMed ID: 28942360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Prevalence of Bipolar Disorders in Hidradenitis Suppurativa: More Than a Striking Co-existence?
    Esme P; Botsali A
    Dermatol Pract Concept; 2022 Nov; 12(4):e2022208. PubMed ID: 36534520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice.
    Tzellos T; Zouboulis CC
    Dermatol Ther (Heidelb); 2020 Feb; 10(1):63-71. PubMed ID: 31955366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
    Nikolakis G; Kaleta KP; Vaiopoulos AG; Wolter K; Baroud S; Wojas-Pelc A; Zouboulis CC
    Dermatology; 2021; 237(5):673-697. PubMed ID: 32942279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.
    Tzellos T; Zouboulis CC; Gulliver W; Cohen AD; Wolkenstein P; Jemec GB
    Br J Dermatol; 2015 Nov; 173(5):1142-55. PubMed ID: 26153913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.